Abstract
Low and middle income countries have been pledged 120 million covid-19 diagnostic tests, which can provide results in 15 to 30 minutes, by a group of organisations including the Bill and Melinda Gates Foundation and the World Health Organization. The move comes after WHO approved the first rapid point of care covid-19 test for emergency use—SD Biosensor’s test—on 22 September. Several other tests which do not require laboratory processing are also being assessed, including one from Abbott which is currently going through the final stages of approval. Separate agreements between SD Biosensor, Abbott, and the Bill and Melinda Gates Foundation mean a total of 120 million tests will be made available to low and middle income countries. The price is currently set at $5 (£3.9; €4.3) per unit, …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
